Represent

Donate

Lobbying Relationship

Client

TEVA PHARMACEUTICALS USA, INC.

More records

Lobbying firm

TEVA PHARMACEUTICALS USA, INC.

More records

  • Use of Section viii statements in pharmaceutical labeling. FDAs approval of over-the-counter naloxone nasal spray. Changes to Hatch-Waxmans 180-day exclusivity incentive. Changes to FDA approval process for pharmaceuticals. Implementation of the Inflation Reduction Act. Drug pricing proposals. Oversight and reform efforts affecting pharmacy benefit managers, including Pharmacy Benefit Manager Transparency Act (S. 127), Prescription Pricing for the People Act (S. 113), and Drug Price Transparency in Medicaid Act of 2023 (H.R. 1613), and Lower Costs, More Transparency Act (H.R. 5378). Patent reform, including the Preserve Access to Affordable Generics and Biosimilars Act (S.142), Affordable Prescriptions for Patients Act (S.150). Block, Report, and Suspend Suspicious Shipments Act (H.R. 501). Proposals related to drug shortages. Reauthorization of the Pandemic and All Hazards Preparedness Act (PAHPA). S. 1067, Ensuring Timely Access to Generics Act. S. 1339, Pharmacy Benefit Manager Reform Act. S. 1114, Expanding Access to Low-Cost Generics Act of 2023. S. 1552, A bill to require the Secretary of Health and Human Services to conduct a study on the designation of biosimilar biological products as interchangeable. S. 1543, A bill to require regulations concerning the disclosure of direct and indirect compensation from entities providing pharmacy benefit management services or third-party administration services. Biosimilar Red Tape Elimination Act (S. 2305). Appeal of a decision regarding the CTPAT Program (DHS).

Duration: to

General Issues: Health Issues, Trade (Domestic & Foreign), Taxation/Internal Revenue Code, Pharmacy, Copyright/Patent/Trademark, Miscellaneous Tariff Bills, Medicare/Medicaid, Budget/Appropriations

Spending: about $54,290,000 (But it's complicated. Here's why.)

Agencies lobbied since 2008: U.S. Senate, House of Representatives, Health & Human Services - Dept of (HHS), Food & Drug Administration (FDA), Executive Office of the President (EOP), Centers For Medicare and Medicaid Services (CMS), Homeland Security - Dept of (DHS), Natl Security Council (NSC), White House Office, State - Dept of (DOS), U.S. Trade Representative (USTR), Food & Drug Administration (FDA),, Patent & Trademark Office (PTO), U.S. Trade Representative (USTR),, Drug Enforcement Administration (DEA), Health & Human Services - Dept of (HHS), Centers For Medicare and Medicaid Services (CMS), U.S. Customs & Border Protection, Commerce - Dept of (DOC), Health & Human Services - Dept of (HHS),, U.S. Senate,, Federal Trade Commission (FTC)

Bills mentioned

H.R.1628: American Health Care Act of 2017

Sponsor: Diane Black (R-Tenn.)

H.R.2051: FAST Generics Act of 2017

Sponsor: David McKinley (R-W.Va.)

S.637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017

Sponsor: Ron Wyden (D-Ore.)

S.771: Improving Access To Affordable Prescription Drugs Act

Sponsor: Al Franken (D-Minn.)

S.469: Affordable and Safe Prescription Drug Importation Act

Sponsor: Bernard Sanders (ID-Vt.)

H.R.749: Lower Drug Costs through Competition Act

Sponsor: Kurt Schrader (D-Ore.)

H.R.9: Innovation Act

Sponsor: Robert W. Goodlatte (R-Va.)

H.R.1353: PATIENT Act of 2015

Sponsor: Gus Bilirakis (R-Fla.)

H.R.406: Combination Drug Development Incentive Act of 2015

Sponsor: Jason Chaffetz (R-Utah)

H.R.486: Stop Tampering of Prescription Pills Act of 2013

Sponsor: Bill Keating (D-Mass.)

S.CON.RES.8: An original concurrent resolution setting forth the congressional budget...

Sponsor: Patty Murray (D-Wash.)

H.R.1919: Safeguarding America's Pharmaceuticals Act of 2013

Sponsor: Robert E. Latta (R-Ohio)

S.959: Pharmaceutical Quality, Security, and Accountability Act

Sponsor: Tom Harkin (D-Iowa)

H.R.4800: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Robert B. Aderholt (R-Ala.)

H.R.2985: Combination Drug Development Incentive Act of 2013

Sponsor: Jason Chaffetz (R-Utah)

H.R.3717: Helping Families in Mental Health Crisis Act of 2013

Sponsor: Tim Murphy (R-Pa.)

S.214: Preserve Access to Affordable Generics Act

Sponsor: Amy Klobuchar (D-Minn.)

S.504: FAIR Generics Act

Sponsor: Al Franken (D-Minn.)

S.296: Preserving Access to Life-Saving Medications Act

Sponsor: Amy Klobuchar (D-Minn.)

S.1357: A bill to exempt National Forest System land in the State of Alaska from...

Sponsor: Mark Begich (D-Alaska)

S.1882: FAIR Generics Act

Sponsor: Jeff Bingaman (D-N.M.)

H.R.4332: Generic Drug Application Review Fairness Act of 2012

Sponsor: Frank Pallone (D-N.J.)

S.2295: Patient Safety and Generic Labeling Improvement Act

Sponsor: Patrick J. Leahy (D-Vt.)

S.330: Consumer Recall Protection Act of 2011

Sponsor: Charles E. Schumer (D-N.Y.)

S.27: Preserve Access to Affordable Generics Act

Sponsor: Herb Kohl (D-Wis.)

H.R.5698: To suspend temporarily the duty on...

Sponsor: Erik Paulsen (R-Minn.)

H.R.5: Protecting Access to Healthcare Act

Sponsor: Phil Gingrey (R-Ga.)

S.23: America Invents Act

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1249: Leahy-Smith America Invents Act

Sponsor: Lamar Smith (R-Texas)

H.R.5561: Emergency Contraception Education Act of 2010

Sponsor: Louise M. Slaughter (D-N.Y.)

S.3504: Emergency Contraception Education Act of 2010

Sponsor: Patty Murray (D-Wash.)

H.R.1859: Independent Drug Education and Outreach Act of 2009

Sponsor: Frank Pallone (D-N.J.)

S.767: Independent Drug Education and Outreach Act of 2009

Sponsor: Herb Kohl (D-Wis.)

H.R.1260: Patent Reform Act of 2009

Sponsor: John Conyers Jr. (D-Mich.)

S.515: Patent Reform Act of 2009

Sponsor: Patrick J. Leahy (D-Vt.)

S.610: Patent Reform Act of 2009

Sponsor: Jon Kyl (R-Ariz.)

H.R.1706: Protecting Consumer Access to Generic Drugs Act of 2009

Sponsor: Bobby L. Rush (D-Ill.)

S.369: Preserve Access to Affordable Generics Act

Sponsor: Herb Kohl (D-Wis.)

S.1315: Drug Price Competition Act of 2009

Sponsor: Bill Nelson (D-Fla.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.4872: Health Care and Education Reconciliation Act of 2010

Sponsor: John M. Spratt Jr. (D-S.C.)

S.301: Physician Payments Sunshine Act of 2009

Sponsor: Charles E. Grassley (R-Iowa)

H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

S.726: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Charles E. Schumer (D-N.Y.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

S.623: Access to Life-Saving Medicine Act

Sponsor: Charles E. Schumer (D-N.Y.)

S.438: Fair Prescription Drug Competition Act

Sponsor: John D. Rockefeller IV (D-W.Va.)

H.R.806: To amend the Federal Food, Drug, and Cosmetic Act to prohibit the...

Sponsor: Jo Ann Emerson (R-Mo.)

H.R.1956: Patient Protection and Innovative Biologic Medicines Act of 2007

Sponsor: Jay Inslee (D-Wash.)

H.R.5629: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

H.R.1038: Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

S.1505: Affordable Biologics for Consumers Act

Sponsor: Judd Gregg (R-N.H.)

S.1695: Biologics Price Competition and Innovation Act of 2007

Sponsor: Edward M. Kennedy (D-Mass.)

H.R.3610: Food and Drug Import Safety Act of 2007

Sponsor: John D. Dingell (D-Mich.)

S.28: Generics First Act of 2007

Sponsor: Herb Kohl (D-Wis.)

H.R.3624: Consumer Food Safety Act of 2007

Sponsor: Frank Pallone (D-N.J.)

H.R.1432: Preserve Access to Affordable Generics Act

Sponsor: Henry A. Waxman (D-Calif.)

S.316: Preserve Access to Affordable Generics Act

Sponsor: Herb Kohl (D-Wis.)

H.R.1908: Patent Reform Act of 2007

Sponsor: Howard L. Berman (D-Calif.)

S.1145: Patent Reform Act of 2007

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.1902: Protecting Consumer Access to Generic Drugs Act of 2007

Sponsor: Bobby L. Rush (D-Ill.)

S.25: Citizen Petition Fairness and Accuracy Act of 2007

Sponsor: Herb Kohl (D-Wis.)

S.3600: Patent Reform Act of 2008

Sponsor: Jon Kyl (R-Ariz.)

S.1951: Fair Medicaid Drug Payment Act of 2007

Sponsor: Max Baucus (D-Mont.)

H.R.3700: Fair Medicaid Drug Payment Act of 2007

Sponsor: Frank Pallone (D-N.J.)

H.R.3140: Saving Our Community Pharmacies Act of 2007

Sponsor: Nancy E. Boyda (D-Kan.)

H.R.3161: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Rosa DeLauro (D-Conn.)

S.1859: Agriculture, Rural Development, Food and Drug Administration, and...

Sponsor: Herb Kohl (D-Wis.)

H.R.5839: Safeguarding America's Pharmaceuticals Act of 2008

Sponsor: Steve Buyer (R-Ind.)

S.2029: Physician Payments Sunshine Act of 2007

Sponsor: Charles E. Grassley (R-Iowa)

S.340: CREATES Act of 2019

Sponsor: Patrick J. Leahy (D-Vt.)

H.R.965: CREATES Act of 2019

Sponsor: David Cicilline (D-R.I.)

H.R.985: FAST Generics Act of 2019

Sponsor: Peter Welch (D-Vt.)

S.64: Preserve Access to Affordable Generics and Biosimilars Act

Sponsor: Amy Klobuchar (D-Minn.)

H.R.1499: Protecting Consumer Access to Generic Drugs Act of 2019

Sponsor: Bobby L. Rush (D-Ill.)

H.R.1344: Competitive DRUGS Act of 2019

Sponsor: Lloyd Doggett (D-Texas)

H.R.938: BLOCKING Act of 2019

Sponsor: Kurt Schrader (D-Ore.)

H.R.1506: FAIR Generics Act

Sponsor: Nanette Barragán (D-Calif.)

H.R.1520: Further Extension of Continuing Appropriations Act, 2021

Sponsor: Anna G. Eshoo (D-Calif.)

H.R.1503: Orange Book Transparency Act of 2020

Sponsor: Robin Kelly (D-Ill.)

S.344: Hatch-Waxman Integrity Act of 2019

Sponsor: Thom Tillis (R-N.C.)

H.R.990: Hatch-Waxman Integrity Act of 2019

Sponsor: Bill Flores (R-Texas)

S.1895: Lower Health Care Costs Act

Sponsor: Lamar Alexander (R-Tenn.)

S.2543: Prescription Drug Pricing Reduction Act of 2019

Sponsor: Charles E. Grassley (R-Iowa)

H.R.3199: Terminating the Extension of Rights Misappropriated Act of 2019

Sponsor: Hakeem Jeffries (D-N.Y.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.4597: ACCESS for Biosimilars Act of 2019

Sponsor: Scott Peters (D-Calif.)

H.R.4455: BIOSIM Act

Sponsor: Kurt Schrader (D-Ore.)

H.R.6179: Increasing Access to Biosimilars Act of 2020

Sponsor: Tony Cárdenas (D-Calif.)

H.R.4629: Star Rating for Biosimilars Act

Sponsor: Paul Tonko (D-N.Y.)

S.164: Advancing Education on Biosimilars Act of 2021

Sponsor: Margaret Hassan (D-N.H.)

S.415: A bill to amend the Federal Food, Drug, and Cosmetic Act with respect to...

Sponsor: Bill Cassidy (R-La.)

H.R.19: Lower Costs, More Cures Act of 2021

Sponsor: Cathy McMorris Rodgers (R-Wash.)

H.R.153: Protecting Consumer Access to Generic Drugs Act of 2021

Sponsor: Bobby L. Rush (D-Ill.)

H.R.2815: BIOSIM Act

Sponsor: Kurt Schrader (D-Ore.)

H.R.2831: Prompt Approval of Safe Generic Drugs Act

Sponsor: Nanette Barragán (D-Calif.)

H.R.2843: STOP GAMES Act of 2021

Sponsor: Andy Levin (D-Mich.)

H.R.2846: Ensuring Access to Lower-Cost Medicines for Seniors Act of 2021

Sponsor: David McKinley (R-W.Va.)

H.R.2853: Bringing Low-cost Options and Competition while Keeping Incentives for...

Sponsor: Kurt Schrader (D-Ore.)

S.1462: Simplifying the Generic Drug Application Process Act

Sponsor: Bill Cassidy (R-La.)

S.1463: Modernizing Therapeutic Equivalence Rating Determination Act

Sponsor: Bill Cassidy (R-La.)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.2873: Affordable Prescriptions for Patients Through Promoting Competition Act...

Sponsor: David Cicilline (D-R.I.)

H.R.2891: Preserve Access to Affordable Generics and Biosimilars Act

Sponsor: Jerrold Nadler (D-N.Y.)

H.R.2884: Affordable Prescriptions for Patients Through Improvements to Patent...

Sponsor: Hank Johnson (D-Ga.)

H.R.2883: Stop Stalling Access to Affordable Medications

Sponsor: Hakeem Jeffries (D-N.Y.)

H.R.2870: Essential Medicines Strategic Stockpile Act of 2021

Sponsor: Buddy Carter (R-Ga.)

S.3799: PREVENT Pandemics Act

Sponsor: Patty Murray (D-Wash.)

H.R.7032: Increasing Transparency in Generic Drug Applications Act of 2022

Sponsor: Ann McLane Kuster (D-N.H.)

H.R.7035: Biologics Market Transparency Act of 2022

Sponsor: Kathy Manning (D-N.C.)

H.R.7047: Lowering Costs by Improving Biosimilar Uptake Act

Sponsor: Kurt Schrader (D-Ore.)

H.R.1730: Speeding Therapy Access Today Act of 2021

Sponsor: Gus Bilirakis (R-Fla.)

H.R.2565: FDA Modernization Act of 2021

Sponsor: Vern Buchanan (R-Fla.)

H.R.3085: ENACT Act of 2021

Sponsor: Lisa Blunt Rochester (D-Del.)

H.R.3927: MADE in America Act

Sponsor: Buddy Carter (R-Ga.)

H.R.6963: Accelerated Approval Integrity Act of 2022

Sponsor: Frank Pallone (D-N.J.)

H.R.6973: Enhanced Access to Affordable Medicines Act of 2022

Sponsor: Buddy Carter (R-Ga.)

H.R.7006: INSPECTIONS Act

Sponsor: Morgan Griffith (R-Va.)

H.R.5376: Inflation Reduction Act of 2022

Sponsor: John Yarmuth (D-Ky.)

H.R.2617: Consolidated Appropriations Act, 2023

Sponsor: Gerald E. Connolly (D-Va.)

S.127: Pharmacy Benefit Manager Transparency Act of 2023

Sponsor: Maria Cantwell (D-Wash.)

S.113: Prescription Pricing for the People Act of 2023

Sponsor: Charles E. Grassley (R-Iowa)

H.R.1613: Drug Price Transparency in Medicaid Act of 2023

Sponsor: Buddy Carter (R-Ga.)

S.142: Preserve Access to Affordable Generics and Biosimilars Act

Sponsor: Amy Klobuchar (D-Minn.)

S.150: Affordable Prescriptions for Patients Act of 2023

Sponsor: John Cornyn (R-Texas)

H.R.501: Block, Report, and Suspend Suspicious Shipments Act

Sponsor: Diana Harshbarger (R-Tenn.)

S.1067: Ensuring Timely Access to Generics Act of 2023

Sponsor: Jeanne Shaheen (D-N.H.)

S.1339: Pharmacy Benefit Manager Reform Act

Sponsor: Bernard Sanders (ID-Vt.)

S.1114: Expanding Access to Low-Cost Generics Act of 2023

Sponsor: Tina Smith (D-Minn.)

S.1552: Coastal Fellowships Act

Sponsor: Christopher A. Coons (D-Del.)

S.1543: A bill to require regulations concerning the disclosure of direct and...

Sponsor: Roger Marshall (R-Kan.)

H.R.5378: Lower Costs, More Transparency Act

Sponsor: Cathy McMorris Rodgers (R-Wash.)

S.2305: Biosimilar Red Tape Elimination Act

Sponsor: Mike Lee (R-Utah)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Robert Falb Rep. Visclosky, LA & LD (until 1991)
Grant Erdel Rep. Charles Bass, Legislative Director (2011-12)
Susie Ahn Health Counsel, Sen. Bill Nelson (2010-12) Sr. L.A., Rep. Mike Honda (2001-04) L.A., Rep Xavier Becerra (2000-2001) Health Counsel, Sen. Bill Nelson (2012-12) L.A., Rep. Xavier Becerra (2000-01)
Bobby Clark Policy Advisor, H Energy & Comm. Cmt.(2007-10 Leg. Assist., Rep. Frank Pallone (2004-07) Staff Assist., Rep. Frank Pallone (2003-04) Policy Advisor, H.Energy & Comm. Cmt (2007-10) Policy Advisor, H.Energy & Comm.Cmt.(2007-10)
David Sanders Patent & Trademark Office - Government Affairs
James Fenton Chief of Staff, Leg. Director, & Staff Assist. to Sen. Chris Dodd, and Prof. Staff Member of Senate HELP Subcommittee on Children & Families, Chaired by Sen. Dodd (1996-2011)
Michael Brzica Legislative Counsel, Rep. Lee Terry (2007-2009)
DEBRA BARRETT n/a
Shannon Dzubin n/a
Dolly Judge n/a
Terri Stewart n/a
Debra S. Barrett n/a
Rob Falb n/a
Colman Ragan n/a
Beena Patel n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Q3 Report
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Amendment
Q1 Report
Q4 Report
Q3 Report
Amendment
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Amendment
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Amendment
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Amendment
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Amendment
Q1 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page